Follicular lymphoma (FL) is a common disease with clinically indolent behavior, and a long
natural history for the majority of patients. Despite excellent therapeutic strategies currently …

Introduction: Patients with follicular lymphoma (FL) have classically had a higher risk of solid
cancers than the general population, but there is little data available in patients diagnosed …

BACKGROUND: Abnormal immune function is a key factor in predisposition to non-Hodgkin
lymphoma (NHL). We evaluated the association of 30 cytokines individually and as a profile …

Background Follicular lymphoma (FL) is the most common indolent non-Hodgkin lymphoma,
with median age at diagnosis in the seventh decade. FL in young adults (YAs), defined as …

Obesity is associated with altered immune and inflammatory responses and it may therefore
influence the risk of non‐Hodgkin's lymphoma. However, epidemiologic findings on obesity …

The transformation to a more aggressive phase in follicular lymphoma (FL) is clinically
marked by rapidly enlarging lymph nodes, development of B-symptoms and often rapidly …

Available epidemiological reports on follicular lymphoma (FL) often highlight a significant
discrepancy between its high and low incidence rates in Western and Eastern Europe …

Abstract The Prognostic Nutritional Index (PNI), a parameter combining serum albumin
concentration and absolute lymphocyte count, is considered a measure of the nutritional and …

Dear Editor, We read with interest the recently published article, BGeriatric nutritional risk
index as a prognostic factor in patients with diffuse large B cell lymphoma^ by Kanemasa et …

Follicular lymphoma (FL) accounts for 10%–15% of non-Hodgkin's lymphomas in western
countries. 1 Although patients with FL experience a relatively indolent course and usually …